Abstract:Dilated cardiomyopathy (DCM) is characterized by left ventricular dilation and cardiac fibrosis. Emerging evidence indicated that endothelial-to-mesenchymal transition (Endo-MT) is a crucial event during organ fibrosis. This study was performed to clarify whether Endo-MT contributed to the progression of cardiac fibrosis in DCM. Cardiac samples from patients with DCM and control were obtained. The presence of endothelial markers, cluster of differentiation (CD)31 and vascular endothelial (VE)-cadherin, and mesenchymal markers, smooth muscle actin (SMA) and fibroblast-specific protein 1 (FSP1) was performed using immunohistochemistry. Co-localization of endothelial markers and mesenchymal markers were identified using confocal immunofluorescence staining. Serum procollagen type I carboxy-terminal propeptide (PICP) and procollagen type III amino-terminal propeptide (PIIINP) were measured by ELISA. Protein levels of Wnt, -catenin and Snail were determined using western blot analysis. Immunohistochemistry and double-immunofluorescence staining demonstrated that the expression of CD31 and VE-cadherin were significantly decreased in DCM samples, whereas the FSP-1, and SMA were significantly increased. CD31 and VE-cadherin labeling indexes were respectively negatively correlated with left ventricular end-diastolic diameter (LVEDD) (CD31 r=-0.82, P<0.01; VE-cadherin r=-0.73, P<0.01), while FSP-1 and SMA were positively associated with LVEDD (SMA r=0.65, P<0.01, FSP1 r=0.53, P<0.01) and left ventricular ejection fraction (SMA r=-0.18, P<0.05; FSP1 r=-0.21, P<0.05). Furthermore, PICP and PIIINP levels were positively associated with the co-expression labeling indexes (CD31/SMA co-labeling index and PICP r=0.727, P<0.01; CD31/SMA co-labeling index and PIIINP r=0.741, P<0.01; VE-Cadherin/FSP-1 co-labeling index and PICP r=0.716, P<0.01; VE-cadherin/FSP-1 co-labeling index and PIIINP r=0.648, P<0.05). Western blot analysis indicated that proteins levels of Wnt signaling and snail were significantly increased in DCM samples. These results suggested that Endo-MT is potentially implicated in the pathogenesis of myocardial fibrosis and remodeling during the development of DCM, indicating a potential therapeutic target for DCM treatment.

[The Expression and Significance of Myocardial Cathepsin L in Dilated Cardiomyopathy].

Relationship Between Cathepsin L and Dilated Cardiomyopathy

A Preliminary Study on the Relationship Between Cathepsin B and Dilated Cardiomyopathy

Enhanced myocardial cathepsin B expression in patients with dilated cardiomyopathy.

Transcriptome Analysis Uncovers the Autophagy‐mediated Regulatory Patterns of the Immune Microenvironment in Dilated Cardiomyopathy

Association Between SCN5A R225Q Variant and Dilated Cardiomyopathy: Potential Role of Intracellular Ph and WNT/β-catenin Pathway

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Cathepsin L is up-expressed in atherosclerotic lesion induced by shear stress.

Cathepsin S-mediated Fibroblast Trans-Differentiation Contributes to Left Ventricular Remodelling after Myocardial Infarction.

Abstract MP216: Identification Of Novel Phosphoprotein Signaling Pathways In Human Dilated Cardiomyopathy By Integrative Proteomic And Phosphoproteomic Analysis

E64d Deteriorates Post-Myocardial Infarction Left Ventricular Remodelling by Inhibiting Cathepsin S-Mediated Fibroblast Trans-Differentiation

The Expression of Chromogranin A in Dilated Cardiomyopathy

Endothelial‑to‑mesenchymal transition in human idiopathic dilated cardiomyopathy.

Cathepsin L Activity is Essential to Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice

Cathepsin C Is Involved in Macrophage M1 Polarization via p38/MAPK Pathway in Sudden Cardiac Death

[Association Between Expression of Chromogranin A and Myocardial Fibrosis in Patients with Dilated Cardiomyopathy].

The Molecular Role of Immune Cells in Dilated Cardiomyopathy

In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy

Abnormal myocardial cytoskeletal proteins in patients with end-stage dilated cardiomyopathy

Abnormal expression of cytoskeletal proteins in patients with dilated cardiomyopathy

Expression and Significance of Coxsackie-Adenovirus Receptor in Myocardia With Dilated Cardiomyopathy